Attenuation of Hemodynamic Response to Laryngoscopy and Endotracheal Intubation With Single Dose of Dexmedetomidine in Hypertensive Patients.
Not Applicable
Completed
- Conditions
- Stress Response During Laryngoscopy Intubation
- Interventions
- Drug: DexmedetomidineDrug: sterile saline
- Registration Number
- NCT03204006
- Lead Sponsor
- Assiut University
- Brief Summary
Attenuation of Hemodynamic Response to Laryngoscopy and Endotracheal Intubation With Single Dose of Dexmedetomidine in Hypertensive Patients.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 70
Inclusion Criteria
-
- Age group 20-60 years
- ASA grade 1 and 2
- control hypertensive patients.
Read More
Exclusion Criteria
-
- Consent not given
- ASA Grade 3 and 4
- history of myocardial ischemia or infarction, or had an abnormal ECG on admission to the hospital
- Patients with cardiovascular, pulmonary, hepatic, and renal disease.
- Patients on B blockers.
- patients with difficult airway; laryngoscopy and intubation time more than 20 s, or requiring more than two attempts will be exclude from the study.
Read More
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Dexmedetomidine group Dexmedetomidine 35 patients will receive dexmedetomidine 0.5 µg/kg was administered intravenously using a syringe pump over 10 min sterile saline pre-induction of anesthesia. Control group sterile saline 35 patients will receive sterile saline 0.5 µg/kg was administered intravenously using a syringe pump over 10 min pre-induction of anesthesia.
- Primary Outcome Measures
Name Time Method heart rate through first 15 min post-induction of anesthesia
- Secondary Outcome Measures
Name Time Method systolic blood pressure through first 15 min post-induction of anesthesia diastolic blood pressure through first 15 min post-induction of anesthesia
Trial Locations
- Locations (1)
Assiut University Hospital
🇪🇬Assiut, Egypt